Plain-English translation of NCT05673915 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcranial direct current stimulation (tDCS)—a non-invasive procedure where gentle electrical currents are delivered to your scalp through electrodes—to see if it can help reduce seizures in people whose epilepsy hasn't been well-controlled by anti-seizure medications. Previous research suggests this treatment may lead to meaningful seizure reduction, even for a few weeks after treatment ends. This study will also test whether you can safely use the device at home.
Many people with epilepsy continue to have seizures even when taking multiple anti-seizure medications, and they need other options. This trial exists to better understand whether this treatment can help, and to figure out if it's safe and practical for people to use on their own at home.
You likely qualify if…
You likely don't qualify if…
You would participate in two separate 2-month treatment periods. During each period, you'll receive transcranial direct current stimulation—electrodes placed on your scalp will deliver gentle electrical currents while you're awake. The study will test two different stimulation levels to see which works better and is safer. You'll need to keep a daily seizure diary and attend regular visits with the research team. Some of the stimulation sessions may be done at home once the team confirms it's safe for you.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States
Sponsor
Mayo Clinic
Enrollment target
~30 participants
Started
April 2023
Primary completion
December 2026
Age range
6 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Precylla Ruiz
Mayo Clinic
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.